Parecer de pré-exame
#6.23
07/15/2025
RPI 2845
Application data
Number
112020005482Type
Filing
Publication
PCT
EP2018074522 The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.
Latest action published by the INPI: 07/15/2025. We update with every new RPI gazette, published weekly.
Applicants
TILLOTTS PHARMA AG
CH
Inventors
E. F. (pessoa física)
CH
IPC Classification
Priority claims
EP
17191989.7 · 09/19/2017
Abstract
A presente invenção se refere a anticorpos que se ligam ao TNFa e exibem ligação ao FcRn modificada. Os anticorpos da invenção têm boas funções efetoras e/ou propriedades farmacocinéticas.
Publications in the Brazilian Industrial Property Gazette (RPI).
#6.23
07/15/2025
RPI 2845
#15.35
11/23/2021
RPI 2655
#1.3
09/29/2020
RPI 2595
#1.1
09/15/2020
RPI 2593
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.